PROTIA will showcase its advanced veterinary diagnostic technologies at the Western Veterinary Conference in Las Vegas, Nevada, from March 2 to 5 at the Mandalay Bay Convention Center. The event will feature over 600 companies and attract more than 20,000 visitors, including veterinary professionals worldwide. The company will highlight three key diagnostic products: 'ANITIA Canine/Feline IgE', 'ANITIA Equine IgE', and 'AniCheck Bovine/Equine IgG'. The 'ANITIA Canine/Feline IgE' kit enables rapid and accurate allergen identification in dogs and cats, allowing veterinarians to develop targeted treatment plans.
PROTIA's 'ANITIA Equine IgE', launched in July 2024, represents a significant advancement in equine health diagnostics. Utilizing a Parallel Line Array system, the product can diagnose 120 allergens through equine serum, providing veterinarians with comprehensive insights into potential allergic reactions in horses. Another notable product is the 'AniCheck Bovine/Equine IgG', which measures IgG concentration in colostrum within 10 minutes. This technology helps select high-quality colostrum rich in immune substances, potentially increasing survival rates and reducing disease incidence in newborn calves and foals.
PROTIA's CEO, Lim Kook-Jin, emphasized the company's commitment to developing innovative diagnostic technologies for companion and large animal health management. The WVC participation represents a strategic opportunity to introduce these technologies to the global veterinary market and foster international collaborations. The exhibition is expected to serve as a significant platform for PROTIA to expand its global market influence, share recent research achievements, and strengthen its international professional network in the veterinary diagnostics sector. For more information about PROTIA's products, visit https://www.protia.com.
